Cytek Biosciences, Inc. (CTKB) vs QuidelOrtho Corporation (QDEL)

Cytek Biosciences, Inc. and QuidelOrtho Corporation are both Medical Devices companies. Cytek Biosciences, Inc. and QuidelOrtho Corporation are of similar size ($744.8M and $733.1M). Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.44% against −2.46%. Cytek Biosciences, Inc. has the higher net margin (−39.0% vs −39.2%) and the lower return on invested capital (−46.4% vs −11.4%). Across the 18 metrics below, Cytek Biosciences, Inc. leads on 13 and QuidelOrtho Corporation on 5.

Valuation

Metric CTKB QDEL Medical Devices median
P/E n/m n/m 22.18
P/S 3.56 0.28 2.70
P/B 2.28 0.42 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 10.44 11.78
EV/Sales 2.29 1.31 2.38
Earnings yield (10.92%) (141.90%) (8.22%)
Free cash flow yield (1.63%) (28.53%) (7.80%)

Profitability

Metric CTKB QDEL Medical Devices median
Gross margin 53.23% 44.60% 56.01%
Operating margin (21.60%) (30.84%) (15.03%)
Net margin (38.98%) (39.20%) (20.40%)
Free cash flow margin (5.79%) (7.90%) (7.24%)
Return on equity (23.04%) (45.91%) (15.32%)
Return on assets (17.14%) (17.34%) (19.72%)
Return on invested capital (46.36%) (11.35%) (10.33%)

Growth

Metric CTKB QDEL Medical Devices median
Revenue growth (TTM) 5.44% (2.46%) 8.80%
EPS growth (last fiscal year) (940.00%) 44.66% —
Revenue growth, 5-year CAGR 16.76% 10.44% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTKB QDEL Medical Devices median
Debt to equity 0.00 1.63 0.07
Current ratio 4.48 1.39 2.50
Net debt to EBITDA 9.19 11.10 0.49

Dividend

Metric CTKB QDEL Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CTKB QDEL Medical Devices median
Market cap 744.80m 733.07m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack